Pathologic findings in radical prostatectomy specimens from patients eligible for active surveillance with highly selective criteria: A multicenter study

Urology

Volumn 80, Issue 3, 2012, Pages 656-660

  Beauval, Jean Baptiste ^a   Ploussard, Guillaume ^b   Soulié, Michel ^a   Pfister, Christian ^c   Van Agt, Simon ^c   Vincendeau, Sébastien ^d   Larue, Sébastien ^e   Rigaud, Jérome ^e   Gaschignard, Nicolas ^f   Rouprêt, Morgan ^g   Drouin, Sarah ^g   Peyromaure, Mickael ^h   Long, Jean Alexandre ⁱ   Iborra, Francois ^j   Vallancien, Guy ^k   Rozet, Francois ^k   Salomon, Laurent ^b  

^a CHU RANGUEIL   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c HÔPITAL CHARLES NICOLLE   (France)

^d Rennes Hospital   (France)

^e Nantes Hospital   (France)

^f Urology Department   (France)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^h Cochin Hospital ^*  (France)

ⁱ GRENOBLE UNIVERSITY HOSPITAL   (France)

^j LAPEYRONIE HOSPITAL   (France)

^k Montsouris Institute   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BIOCHEMICAL RECURRENCE FREE SURVIVAL; CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; TUMOR VOLUME;

AGED; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; WATCHFUL WAITING;

EID: 84865476624     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2012.04.051     Document Type: Article

References (25)

1. X. Rbillard, P. Grosclaude, T. Lebret Projected incidence and mortality from urologic cancer in France in 2010 [Article in French] Prog Urol 20 Suppl 4 2010 S211 S214
2. M.J. Roobol, M. Kerkhof, F.H. Schrder Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC) Eur Urol 56 2009 584 591
3. L. Salomon, D. Azria, C. Bastide Recommendations Onco-Urology 2010: prostate cancer Prog Urol 20 Suppl 4 2010 S217 S251
4. L. Klotz Active surveillance with selective delayed intervention for favorable risk prostate cancer Urol Oncol 24 2006 46 50
5. J.J. Tosoian, B.J. Trock, P. Landis Active surveillance program for prostate cancer: an update of the Johns Hopkins experience J Clin Oncol 29 2011 2185 2190
6. S.L. Conti, M. Dall'era, V. Fradet Pathological outcomes of candidates for active surveillance of prostate cancer J Urol 181 2009 1628 1634 discussion 1633-1634
7. J.I. Epstein, P.C. Walsh, M. Carmichael Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer JAMA 271 1994 368 374
8. M.A. Dall'Era, B.R. Konety, J.E. Cowan Active surveillance for the management of prostate cancer in a contemporary cohort Cancer 112 2008 2664 2670
9. N. Suardi, U. Capitanio, F.K. Chun Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic features Cancer 113 2008 2068 2072
10. G. Ploussard, J.I. Epstein, R. Montironi The contemporary concept of significant versus insignificant prostate cancer Eur Urol 60 2011 291 303
11. S.E. Lee, D.S. Kim, W.K. Lee Application of the Epstein criteria for prediction of clinically insignificant prostate cancer in Korean men BJU Int 105 2010 1526 1530
12. R.C. van den Bergh, S. Roemeling, M.J. Roobol Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly Eur Urol 55 2009 1 8
13. L. Klotz, L. Zhang, A. Lam Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer J Clin Oncol 28 2010 126 131
14. P.A. Johnstone, P.J. Rossi, A.B. Jani "Insignificant" prostate cancer on biopsy: pathologic results from subsequent radical prostatectomy Prostate Cancer Prostatic Dis 10 2007 237 241
15. F.K. Chun, N. Suardi, U. Capitanio Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy Eur Urol 55 2009 617 628
16. C. Jeldres, N. Suardi, J. Walz Validation of the contemporary Epstein criteria for insignificant prostate cancer in European men Eur Urol 54 2008 1306 1313
17. M.C. Lee, F. Dong, A.J. Stephenson The Epstein criteria predict for organ-confined but not insignificant disease and a high likelihood of cure at radical prostatectomy Eur Urol 58 2010 90 95
18. A.F. Kotb, S. Tanguay, M.A. Luz Relationship between initial PSA density with future PSA kinetics and repeat biopsies in men with prostate cancer on active surveillance Prostate Cancer Prostatic Dis 14 2011 53 57
19. M. Auprich, F.K. Chun, J.F. Ward Critical assessment of preoperative urinary prostate cancer antigen 3 on the accuracy of prostate cancer staging Eur Urol 59 2011 96 105
20. V. Fradet, J. Kurhanewicz, J.E. Cowan Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging Radiology 256 2010 176 183
21. S.J. Freedland, W.B. Isaacs, E.A. Platz Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study J Clin Oncol 23 2005 7546 7554
22. G. Ploussard, E. Xylinas, X. Durand Magnetic resonance imaging does not improve the prediction of misclassification of prostate cancer patients eligible for active surveillance when the most stringent selection criteria are based on the saturation biopsy scheme BJU Int 108 2011 513 517
23. R.K. Berglund, T.A. Masterson, K.C. Vora Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance J Urol 180 2008 1964 1967 discussion 1967-1968
24. P.N. Harnden, B. Naylor, M.D. Shelley The clinical management of patients with a small volume of prostatic cancer on biopsy: what are the risks of progression? A systematic review and meta-analysis Cancer 112 2008 971 981
25. C.S. Thaxton, S. Loeb, K.A. Roehl Treatment outcomes of radical prostatectomy in potential candidates for 3 published active surveillance protocols Urology 75 2010 414 418